Ezetimibe
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5330 publications
Evaluating enlicitide decanoate: first oral PCSK9 inhibitor for the treatment of adults with hypercholesterolemia.
Journal: Expert opinion on pharmacotherapy
Published: September 08, 2026
Review of the American Heart Association PREVENT guidelines: how non-high-density lipoprotein cholesterol and apolipoprotein B fit in.
Journal: Laboratory medicine
Published: August 26, 2026
Sitosterolemia: evolving strategies for earlier diagnosis.
Journal: Current opinion in lipidology
Published: August 24, 2026
Enlicitide (Lipfendra) - an oral PCSK9 inhibitor for LDL-cholesterol lowering.
Journal: The Medical letter on drugs and therapeutics
Published: August 21, 2026
Sitosterolemia: A Rare Cause of Severe Hypercholesterolemia in Children.
Journal: WMJ : official publication of the State Medical Society of Wisconsin
Published: August 20, 2026
Enlicitide: The first oral PCSK9 inhibitor approved for treatment of hypercholesterolemia.
Journal: Drug discoveries & therapeutics
Published: August 16, 2026
Key advances in secondary prevention after coronary artery bypass grafting.
Journal: Current opinion in cardiology
Published: August 13, 2026
Site-specific cholesterol depletion therapy for gastric cancer.
Journal: bioRxiv : the preprint server for biology
Published: July 29, 2026
Hyperlipidemia Management: Comprehensive Review and Looking Forward.
Journal: South Dakota medicine : the journal of the South Dakota State Medical Association
Published: July 28, 2026
Protocol-Based Implementation of Early Intensive Lipid Management After Acute Coronary Syndrome: The BRIDGE Trial.
Journal: Journal of the American College of Cardiology
Published: July 21, 2026
Site-specific cholesterol depletion therapy for gastric cancer.
Journal: Journal of lipid research
Published: July 15, 2026
Last Updated: 09/26/2026